Catheter Precision, Inc. (VTAK)

US — Healthcare Sector
Peers:

Automate Your Wheel Strategy on VTAK

With Tiblio's Option Bot, you can configure your own wheel strategy including VTAK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol VTAK
  • Rev/Share 0.0426
  • Book/Share 0.7015
  • PB 0.6129
  • Debt/Equity 0.2132
  • CurrentRatio 0.2089
  • ROIC -0.6287

 

  • MktCap 4737439.0
  • FreeCF/Share -0.8616
  • PFCF -0.4873
  • PE -0.2694
  • Debt/Assets 0.0681
  • DivYield 0
  • ROE -1.539

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Catheter Precision, Inc. Comments on Recent Market Activity
VTAK
Published: June 12, 2025 by: GlobeNewsWire
Sentiment: Neutral

FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common stock. The Company is not aware of any information related to the Company or its operations that it would have expected to cause increased market activity. The Company continues to pursue its strategic plans as previously disclosed, including its ongoing efforts to secure financing to meet its liquidity needs.

Read More
image for news Catheter Precision, Inc. Comments on Recent Market Activity
Catheter Precision, Inc. Receives CE Mark for LockeT
VTAK
Published: May 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device.

Read More
image for news Catheter Precision, Inc. Receives CE Mark for LockeT

About Catheter Precision, Inc. (VTAK)

  • IPO Date 2018-09-27
  • Website https://www.catheterprecision.com
  • Industry Medical - Devices
  • CEO Mr. David A. Jenkins
  • Employees 22
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.